biotech / news / / Reuters
Initial data from Foundayo's launch is lagging Novo Nordisk's oral Wegovy, which hit the market in January.
Indian drugmakers began selling cheaper generic versions of Novo's injectable Wegovy last month.
KEY POINTS
- Canada approved its first generic version of Novo's Ozempic for diabetes and weight loss use.
- Lilly raised the UK list price of Mounjaro by up to 170% last year.
- Direct-to-consumer sales data may not be reflected in initial launch numbers for Foundayo.
COMPANIES
Summarized by Newsio from Reuters. How we summarize →